hVIVO poster presentation at ERS 2015 (European Respiratory Society International Congress) September 2015October 7, 2015 11:05 am
“Discovering New Treatments for Asthma and COPD. The Use of the Human Viral Challenge Model with a Newly Manufactured and Characterised GMP Wild-Type Human Rhinovirus”.
Daniel J. Fullen, Bryan Murray, Daryl W. Borley, Julie Mori, Andrew Catchpole, Ganesh Balaratnam, Anthony Gilbert, Fiona Hughes & Rob Lambkin-Willams. hVIVO Group PLC, Queen Mary BioEnterprises Innovation Centre, 42 New Road, London , E1 2AX, England.
Human Rhinovirus (HRV) infection is an important precursor to asthma and chronic obstructive pulmonary disease (COPD) exacerbations. The Human Viral Challenge (HVC) model may provide a powerful tool in studying these and other chronic respiratory diseases. In this study, we have reported the production and human characterisation of a new Wild-Type HRV-16 challenge virus produced specifically for this purpose.
Fill out the form below to download the hVIVO poster presentation as made at ERS 2015.